<DOC>
	<DOCNO>NCT01476358</DOCNO>
	<brief_summary>Vitamin A supplementation ( VAS ) significantly reduce all-cause mortality give 6 month age , null detrimental effect give 1-5 month . Studies neonatal VAS ( NNVAS ) produce conflicting finding . These age-pattern variation might result immunological interaction VAS vaccine . The potential efficacy NNVAS retested 3 large new intervention trial mortality endpoint . Complementary mechanistic study animal human infants The Gambia ( proposal ) Bangladesh commission run parallel . The investigator use 2-arm double blind RCT test whether NNVAS modulate early ontogeny human immune development . Neonates , recruit peri-urban clinic The Gambia , receive either 50,000 International Units ( IU ) VAS orally within 48 hour birth ( intervention group , n=100 ) placebo ( control group , n=100 ) . Male female neonate randomize separately enrolment later analyse sex . All infant follow birth age 1 year . A broad panel immunological outcome examine whether NNVAS : ) . normalises thymic development ( thymic index ultrasound ) ; b ) . skews mycobacterial recall antigen response towards Th2 profile ; c ) . diminishes Th1 Th17 reactivity mycobacterial recall antigens ; ) . diminishes tuberculin skin test ( TST ) response ; e ) . cause increase innate immune reactivity ; f ) . increase frequency circulate regulatory T cell ( Tregs ) express gut homing receptor ; g ) . enhance B cell immune response routine vaccination ( increase B cell number activation status ) ; h ) . increase circulate IgA mucosal immune compartment , especially oral polio vaccine ( OPV ) specific IgA post-vaccination ; ) . decrease bacterial translocation , improve mucosal barrier function ; j ) . decrease marker infection inflammation . Growth morbidity also assess .</brief_summary>
	<brief_title>Effect Vitamin A Supplementation Immune Responses Human Neonates</brief_title>
	<detailed_description />
	<mesh_term>Vitamin A Deficiency</mesh_term>
	<mesh_term>Night Blindness</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<mesh_term>Retinol palmitate</mesh_term>
	<criteria>singleton birth , birth weight â‰¥1,500g , mother 18 year willing participate residency within study area . Birth vaccination vitamin A supplement must administer within 48 hour birth . Infants congenital disease , serious infection birth inability feed ( initially assess lack suck reflex ) , mother seriously ill time enrolment ( define bed bound 24 hour ) , mother participate study , mother HIV positive .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>48 Hours</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>